Audicote Acoustical Plaster by United States Gypsum

Product Description

Audicote Acoustical Plaster was a spray-applied and trowel-applied acoustical finish product manufactured by United States Gypsum Company (USG) and sold primarily between 1954 and 1972. The product was designed to reduce noise transmission and improve sound absorption in commercial, institutional, and industrial interior spaces. Its textured, porous surface finish was engineered to dampen sound rather than reflect it, making it a popular specification choice for gymnasiums, auditoriums, office buildings, schools, hospitals, and industrial facilities constructed or renovated during the postwar building boom.

As an acoustical plaster, Audicote belonged to a family of specialty finishing products that were applied directly to ceilings and upper wall surfaces to achieve both functional sound control and a finished aesthetic appearance. Unlike standard gypsum plaster, acoustical plaster formulations incorporated lightweight aggregates and other additives to create the open, fibrous surface structure responsible for their sound-dampening properties. Audicote was marketed under the United States Gypsum brand, a major name in the mid-century American construction materials industry, and appeared in project specifications throughout the United States during its production years.

The product’s overlap with both joint compound applications and ceiling tile installations reflects its dual role as a finishing and acoustic material. In some installations, Audicote was used in conjunction with other gypsum board systems, placing it in workflows that involved a wide range of construction trades and industrial workers.

Asbestos Content

Audicote Acoustical Plaster contained chrysotile asbestos as a component of its formulation during its production years from 1954 through 1972. Chrysotile, also known as white asbestos, is a serpentine-form mineral fiber that was widely incorporated into building materials during this era for its reinforcing properties, fire resistance, and ability to bind other components together in a stable matrix.

In acoustical plaster products, chrysotile fibers served structural and functional roles. The fibrous nature of asbestos complemented the lightweight aggregate systems used in acoustical formulations, helping create the cohesive, porous surface structure that gave the product its sound-absorption characteristics. Chrysotile was also valued for its resistance to heat and moisture, qualities that extended the durability of applied finishes in demanding interior environments.

Although chrysotile asbestos is sometimes characterized as less hazardous than amphibole varieties such as crocidolite or amosite, regulatory and scientific consensus — including standards established under the Asbestos Hazard Emergency Response Act (AHERA) and OSHA’s asbestos standards at 29 C.F.R. § 1910.1001 and 29 C.F.R. § 1926.1101 — treats all asbestos fiber types as hazardous, with no established safe level of occupational exposure. The inhalation of chrysotile fibers has been associated with mesothelioma, asbestosis, and lung cancer.

Audicote’s production timeline — ending in 1972 — coincides with the period during which manufacturers and regulators began formally acknowledging the occupational health hazards of asbestos-containing building materials.

How Workers Were Exposed

Exposure to asbestos-containing Audicote Acoustical Plaster occurred primarily among workers involved in its installation, finishing, and subsequent disturbance during renovation or demolition activities. Industrial workers generally, as well as plasterers, finishers, and construction tradespeople working in proximity to spray or trowel applications, faced the greatest risk of fiber inhalation.

During Mixing and Application: Audicote was supplied in dry powder or concentrate form requiring on-site mixing before application. Workers who opened bags, measured product, and combined materials with water or other components could generate significant airborne dust. Spray application — the method used for many commercial ceiling installations — aerosolized the wet mixture and dispersed fine particles, including asbestos fibers, throughout the work area. Workers directly applying the product, as well as those in adjacent spaces, were potentially exposed during these operations.

During Sanding and Surface Finishing: Once applied, acoustical plaster surfaces often required sanding, trimming, or patching to achieve a uniform finish or to meet specifications. These dry mechanical operations on a hardened asbestos-containing surface could release respirable chrysotile fibers in elevated concentrations. Workers performing these tasks in enclosed ceiling spaces or poorly ventilated interiors faced prolonged exposure during finishing work.

During Renovation, Repair, and Demolition: Buildings constructed between 1954 and 1972 may still contain original Audicote installations in intact or deteriorated condition. Workers involved in building renovation, ceiling replacement, abatement, or demolition in structures from this period can encounter friable or damaged acoustical plaster containing chrysotile asbestos. Disturbance of deteriorated material — whether through mechanical impact, drilling, or removal — releases previously bound fibers into the breathing zone of workers and bystanders.

Bystander Exposure in Industrial Settings: Industrial workers generally present in facilities where Audicote was being applied or disturbed may have experienced secondary or bystander exposure. In industrial environments where Audicote was specified for sound control purposes, ongoing work activities could repeatedly disturb ceiling surfaces, creating chronic low-level fiber release over time.

OSHA’s construction industry asbestos standard recognizes spray-applied acoustical materials as a category of suspected or confirmed asbestos-containing materials in buildings constructed before 1981, requiring specific precautions during disturbance.

Audicote Acoustical Plaster is classified as a Tier 2 litigated product. There is no active asbestos bankruptcy trust fund associated with United States Gypsum Company’s Audicote product line. Individuals seeking compensation for asbestos-related illness connected to Audicote exposure must pursue claims through civil litigation in state or federal court.

Litigation History

Litigation records document claims filed against United States Gypsum Company in connection with asbestos-containing products manufactured under the USG brand, including acoustical plaster formulations. Plaintiffs alleged that USG knew or should have known that chrysotile asbestos incorporated into products such as Audicote posed serious health risks to workers, and that the company failed to provide adequate warnings or to reformulate its products in a timely manner despite the availability of that information.

Plaintiffs alleged that exposure to Audicote during mixing, spray application, sanding, and renovation activities caused or contributed to the development of mesothelioma, asbestosis, and related asbestos-caused diseases. Litigation records document cases brought by industrial workers and construction tradespeople who worked with or around acoustical plaster products manufactured by USG during the product’s active production years.

Pursuing a Claim

Individuals diagnosed with mesothelioma, lung cancer, or asbestosis who have a documented history of occupational exposure to Audicote Acoustical Plaster or similar USG acoustical plaster products may have grounds for civil litigation. Key elements in building a claim typically include establishing product identification through work history records, union documentation, building specifications, or witness testimony; a confirmed diagnosis of an asbestos-related disease; and a causal link between the exposure and the diagnosis.

Statutes of limitations for asbestos personal injury claims vary by state and generally begin running from the date of diagnosis rather than the date of exposure. Individuals or surviving family members of those who have died from asbestos-related disease should consult an attorney experienced in asbestos litigation to evaluate eligibility, applicable deadlines, and available venues for filing suit.

This article is provided for informational and reference purposes. It does not constitute legal advice. Individuals with potential asbestos exposure claims should seek consultation with a qualified attorney.